Recent Updates
Recently added Catalysts
SYRE

Spyre Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic...

Key Takeaway: To access this webcast, please visit the "Events & Presentations" page within the Investors section of the Spyre website at ir.spyre.com. An archive of the webcast will be available for replay following the end of the conference. About Spyre Therapeutics Follow Spyre Therapeuti

Full Press Release Details

To access this webcast, please visit the "Events & Presentations" page within the Investors section of the Spyre website at ir.spyre.com. An archive of the webcast will be available for replay following the end of the conference.
About Spyre Therapeutics
Follow Spyre Therapeutics on social media: @spyretx and LinkedIn
SOURCE Spyre Therapeutics, Inc.

21 %

Last updated: Nov 25, 2024